This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

hypo into molecule

Available via

WEBINAR

Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats

Monday, May 20, 2019

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

 

The development of vaccines against infectious diseases, beginning a few centuries ago, have had a profound impact on human health and longevity. While there are still many serious and potentially preventable infectious diseases for which no effective vaccines are available, the biotech revolution and advances in our understanding of the immune response hold promise to address these challenges. To explore the state of the science today, this symposium will gather the world’s leaders in vaccine development. Together, they will share the latest findings that illuminate the potential and the limits of the human immune system in its response to vaccines, the challenges facing vaccine development, maternal immunizations, and the next era of vaccine technologies.

Registration

Member
By 04/19/2019
$90
After 04/19/2019
$130
Nonmember Academia, Faculty, etc.
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Corporate, Other
By 04/19/2019
$250
After 04/19/2019
$350
Nonmember Not for Profit
By 04/19/2019
$180
After 04/19/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 04/19/2019
$100
After 04/19/2019
$145
Member Student, Post-Doc, Fellow
By 04/19/2019
$50
After 04/19/2019
$70
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Earlybird Registration:
0
days
left
Deadline:
0
days
left

Keynote Speaker

Padmini Srikantiah, MD, MPH

Bill & Melinda Gates Foundation

Speakers

James E. Crowe, Jr., MD
James E. Crowe, Jr., MD

Vanderbilt University

Ann Ginsberg
Ann Ginsberg, MD, PhD**

International AIDS Vaccine Initiative

Gregory Glenn
Gregory Glenn, MD

Novavax

Adrian Hill
Adrian Hill, PhD

University of Oxford

Kathrin Jansen
Kathrin Jansen, PhD

Pfizer

Wayne Koff
Wayne Koff, PhD

Human Vaccines Project

Sallie Permar
Sallie Permar, MD

Duke University

Bali Pulendran
Bali Pulendran, PhD**

Emory University

Rino Rappuoli
Rino Rappuoli, PhD

GlaxoSmithKline

David Weiner, PhD
David Weiner, PhD

The Wistar Institute

Drew Weissman
Drew Weissman, MD, PhD

University of Pennsylvania

Ian Wilson
Ian Wilson, DPhil

The Scripps Research Institute

**not participating in webinar

Organizers

Annaliesa Anderson
Annaliesa Anderson, PhD

Pfizer

Melanie Brickman Borchard
Melanie Brickman Borchard, PhD, MSc

The New York Academy of Sciences

Gregory Glenn
Gregory Glenn, MD

Novavax

Wayne Koff
Wayne Koff, PhD

Human Vaccines Project

Stanley Plotkin, MD
Stanley Plotkin, MD
George Zavoico
George Zavoico, PhD

B. Riley FBR

Event Sponsors




Monday

May 20, 2019

8:10 AM

Registration, Breakfast, and Poster Setup

8:50 AM

Welcome Remarks

Speaker

Melanie Brickman Borchard, PhD, MSc
The New York Academy of Sciences
9:00 AM

Keynote Presentation: The Potential of Vaccines to Address AMR

Speaker

Padmini Srikantiah, MD, MPH
Bill & Melinda Gates Foundation

Session I: New Approaches for Understanding the Immune System for Vaccine Development

Session Chairperson
Wayne Koff, PhD, Human Vaccines Project
9:35 AM

Human Antibodies and Repertoires for Emerging Infectious Diseases

Speaker

James E. Crowe, Jr., MD
Vanderbilt University
10:00 AM

Systems Vaccinology: Probing the Immune Response to Vaccination in Humans

Speaker

Bali Pulendran, PhD **
Emory University (**not participating in webinar)
10:25 AM

Networking Coffee Break

Session II: Taking on the Big Challenges Facing Novel Vaccine Development

Session Chairperson
George Zavoico, PhD, B. Riley, FBR
10:55 AM

New Generation Malaria Vaccines

Speaker

Adrian Hill, PhD
University of Oxford
11:20 AM

TB Vaccine Development and AMR

Speaker

Ann Ginsberg, PhD, MD**
International AIDS Vaccine Initiative (**not participating in webinar)
11:45 AM

The Future of Vaccine Development

Speaker

Wayne Koff, PhD
Human Vaccines Project

Session III: Data Blitz Presentations

Session Chairperson
Melanie Brickman Borchard, PhD, MSc, The New York Academy of Sciences
12:10 PM

FluoroSpot for the Analysis of Zika and Dengue Specific and Cross-Reactive Memory B Cells

Speaker

Anuja Mathew, PhD
University of Rhode Island
12:15 PM

Protective Anti-Viral Antibodies Elicited by Vaccine that Recruit Helper T Cell Activity Induced by Prior BCG Immunization

Speaker

Tony Ng, PhD
Albert Einstein College of Medicine
12:20 PM

Networking Luncheon and Poster Session

Session IV: Vaccines to Protect Newborns: The Next Frontier

Session Chairperson
Annaliesa Anderson, PhD, Pfizer
1:45 PM

Advances in Maternal Immunization

Speaker

Kathrin Jansen, PhD
Pfizer
2:10 PM

Protecting Infants from RSV via Maternal Immunization

Speaker

Greg Glenn, MD
Novavax
2:35 PM

Next Generation Vaccines against Cytomegalovirus: We Are Half Way There

Speaker

Sallie Permar, MD, PhD
Duke University
3:00 PM

Networking Coffee Break

Session V: New Technologies for Vaccine Development

Session Chairperson
Gregory Glenn, MD, Novavax
3:30 PM

Guiding Vaccine Candidates: Antibodies That Can Neutralize Influenza and Malaria

Speaker

Ian Wilson, DPhil
The Scripps Research Institute
3:55 PM

Synthetic DNA Approaches for Difficult Infectious Disease Targets

Speaker

David Weiner, PhD
The Wistar Institute
4:20 PM

mRNA Vaccines A New Era in Vaccinology

Speaker

Drew Weissman, MD, PhD
University of Pennsylvania
4:45 PM

Transforming New Technologies into Vaccines: Genomics, Adjuvants and Self-Amplifying RNAs

Speaker

Rino Rappuoli, PhD
GlaxoSmithKline
5:10 PM

CLOSING REMARKS

Speaker

Melanie Brickman Borchard, PhD
New York Academy of Sciences
5:15 PM

Networking Reception and Poster Session

6:15 PM

End of Day

Loading...